ClinConnect ClinConnect Logo
Search / Trial NCT03427736

Anesthetics and Analgesics in Children

Launched by KANECIA OBIE ZIMMERMAN · Feb 8, 2018

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Anesthetics and Analgesics in Children," is designed to study how anesthetic and pain relief medications work in children and adolescents. Researchers want to understand how these drugs are processed in the body and ensure they are safe for young patients. The trial is currently looking for participants aged from newborns to under 18 years old. Eligible participants must be receiving specific medications as part of their medical care and must have a parent or guardian who can provide consent.

If you or your child join the study, you can expect to work closely with the research team, who will guide you through the process and answer any questions you may have. The study aims to gather important information that can help improve the use of these medications in young patients. It's important to note that children who are pregnant or have certain serious medical conditions may not be eligible for this trial. Overall, this study could contribute valuable insights into the safe use of anesthesia and pain relief in children.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. 0 to \<18 years of age at time of enrollment (must see applicable appendix for details as not all appendices enroll across the entire age range)
  • 2. Parent and/or participant (if applicable) is able to understand the consent process and provides informed consent and HIPAA Authorization (if applicable)
  • 3. Participant provides assent as required by the institutional review board (IRB) or research ethics board (REB)
  • 4. Receiving one or more drugs of interest (DOI) per local standard of care
  • 5. Meeting DOI-specific inclusion criteria (See Appendices)
  • Exclusion Criteria:
  • 1. Known pregnancy
  • 2. Extracorporeal life support (i.e., ECMO, dialysis, ventricular assist device)
  • 3. Any condition which would make the participant, in the opinion of the investigator, unsuitable for the study

About Kanecia Obie Zimmerman

Kanecia Obie Zimmerman is a distinguished clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong background in clinical medicine and a focus on innovative therapies, Zimmerman leads initiatives that prioritize ethical standards, regulatory compliance, and patient safety. Her expertise encompasses a wide range of therapeutic areas, and she is dedicated to fostering collaboration among researchers, clinicians, and stakeholders to drive the development of groundbreaking treatments. Under her guidance, clinical trials are conducted with rigor and integrity, ensuring that they contribute meaningful data to the scientific community and ultimately enhance healthcare practices.

Locations

Houston, Texas, United States

Durham, North Carolina, United States

Charleston, South Carolina, United States

Nashville, Tennessee, United States

Saint Louis, Missouri, United States

Saint Louis, Missouri, United States

Wilmington, Delaware, United States

Portland, Oregon, United States

San Francisco, California, United States

Aurora, Colorado, United States

Toronto, Ontario, Canada

Albuquerque, New Mexico, United States

Houston, Texas, United States

Durham, North Carolina, United States

Stanford, California, United States

Montreal, Quebec, Canada

Chicago, Illinois, United States

Austin, Texas, United States

Patients applied

0 patients applied

Trial Officials

Kanecia Zimmerman

Principal Investigator

Duke Clinical Research Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials